Cohance Lifesciences, a premier pharmaceutical company from India, is investing $10 million to improve cGMP bioconjugation capabilities in the United States. The investment will further strengthen the company’s position in the biologics and ADC...
Indoco Remedies Ltd. has obtained final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application
US pharmaceutical giant Eli Lilly stepped up competition with rival Danish drugmaker Novo Nordisk on Wednesday by introducing its popular diabetes medication Mounjaro in the Indian market. KwikPen is a single patient use prefilled pen intended for on
Senores Pharmaceuticals Limited, its wholly-owned US subsidiary Senores Pharmaceuticals, Inc., has entered into a pact to acquire two USFDA-approved Abbreviated New Drug Applications (ANDAs) of Teva Pharmaceuticals USA, Inc.
Cohance Lifesciences Limited, the partner of choice for global innovative pharma companies, announces Rs. 23 crore investments and good progress on construction of its new cGMP oligonucleotide building block manufacturing facility located in
Zydus Lifesciences, a leading Indian pharmaceutical, is preparing to launch semaglutide variants, the active ingredient in antidiabetic and weight-loss drugs, as the patent nears expiration in 2026. The firm is expected to invest over ?100...
A new treatment by Pfizer’s Padcev and Merck’s Keytruda is showing positive results in patients with advanced bladder cancer. A recent study looked at these two drugs combined and showed that they helped patients live longer and delayed...
Novartis has announced positive top-line data from its Phase III NEPTUNUS-1 and NEPTUNUS-2 trials in active adult Sjögren's disease patients to assess ianalumab (VAY736) efficacy.
The international healthcare company Viatris Inc. reported that iron sucrose injection, USP, an injectable iron replacement product, has been approved by the US Food and Drug Administration (FDA) to treat iron deficiency anemia (IDA) in adult and ped
Sartorius Stedim Biotech, a collaborator with the biopharmaceutical industry, has entered into a collaboration with Nanotein Technologies, a developer of immune cell activation reagents. Sartorius Stedim Biotech intends to invest up to $3 million
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")